Capital Bancorp
CBNK · NASDAQ
About CBNK
- Employees
- 434
- Headquarters
- Rockville, Maryland
- Listed
- Sep 26, 2018
- Sector
- Financials
- Industry
- Banks
- Website
- ir.capitalbankmd.com
CBNK key statistics
- Market cap
- 659.60M
- Price-earnings ratio
- 11.59
- Dividend yield
- 1.19%
- Average volume
- 185.41K
- Volume
- 248.13K
- Open price
- $39.53
- High today
- $40.88
- Low today
- $39.53
- 52 Week high
- $40.70
- 52 Week low
- $26.40
Capital Bancorp (CBNK) at a glance
As of Oct 20, 2026, Capital Bancorp (CBNK) shares are priced at $40.49, giving the company a market cap of 659.60M, a price-to-earnings ratio of 11.59 and a dividend yield of 1.19%.
Today the stock has traded between $39.53 and $40.88. The current price is 2.4% above the day's low and 1.0% below its high.
Volume so far is 248.13K shares, above the average of 185.41K shares a day.
Over the past year Capital Bancorp has ranged from $26.40 to $40.70, and now sits 99% of the way up that range.
Capital Bancorp met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.87 per share against an estimate of $0.8384.
The average analyst price target is $40.99, 1.2% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy25.0%
- Hold75.0%
- Sell0.0%
- Low
- $35.35
- Now
- $40.49
- High
- $45.94
CBNK earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 18.9% on average.
- Q3 FY24: reported $0.66 per share against an estimate of $0.6962
- Q4 FY24: reported $0.92 per share against an estimate of $0.6605
- Q1 FY25: reported $0.88 per share against an estimate of $0.737
- Q2 FY25: reported $0.85 per share against an estimate of $0.8976
- Q3 FY25: reported $0.72 per share against an estimate of $0.854
- Q4 FY25: reported $0.91 per share against an estimate of $0.8043
- Q1 FY26: reported $0.73 per share against an estimate of $0.7918
- Q2 FY26: reported $0.87 per share against an estimate of $0.8384
CBNK news
- Press releasePRNewswire
- Press releaseBusiness Wire
Capital Bancorp Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Capital Bancorp, Inc. - CBNK
- Press releasePRNewswire
Are SSTI, MG, CBNK, MGLD Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
CBNK SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES CAPITAL BANCORP, INC.
- Avi Kapoor
Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views
- Press releaseBusiness Wire
CBNK Stock Alert: Halper Sadeh LLC is Investigating Whether Capital Bancorp, Inc. is Obtaining a Fair Price for its Shareholders
- Avi Kapoor
Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
PEOPLES BANCORP INC. AND CAPITAL BANCORP, INC. ANNOUNCE MERGER AGREEMENT
Similar companies
Companies in the same industry as Capital Bancorp
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.